glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(η6-p-phenylethacrynate)Cl2(pta)] Structural variations of the ligands
Structural variations of the ligands in the lead compound RAPTA C. Download Scientific Diagram Integrative Therapeutics Glutathione Cell Defense State of Metal Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases Oncohema Key RAPTA C (Ru(6 p cymene)Cl2(pta)) Anti cancer Agent, Anti angiogenic Agent MedChemExpress
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] Structural variations of the ligands](https://www.researchgate.net/publication/44579667/figure/fig4/AS:349450833809419@1460326979428/Structural-variations-of-the-ligands-in-the-lead-compound-RAPTA-C.png)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] Structural variations of the ligands](https://supplementfirst.com/cdn/shop/products/Integrative_Therapeutics_Glutathione_Cell_Defense_Full_grande.jpg?v=1700157531)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] Structural variations of the ligands](https://oncohemakey.com/wp-content/uploads/2016/10/A316282_1_En_11_Fig2_HTML.gif)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] Structural variations of the ligands](https://file.medchemexpress.com/product_pic/hy-130326.gif)